You have 9 free searches left this month | for more free features.

Dexamethasone acetate

Showing 1 - 25 of 3,517

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Nov 13, 2023

Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Guangzhou, Guangdong, China
  • +3 more
Aug 16, 2022

Relapsed or Refractory Multiple Myeloma Trial in Beijing (Mitoxantrone Hydrochloride Liposome injection, Bortezomib for

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Mitoxantrone Hydrochloride Liposome injection
  • +2 more
  • Beijing, Beijing, China
    Beijing Chaoyang Hospital, Capital Medical University
Jan 16, 2022

Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,

Not yet recruiting
  • Insulin Resistance
  • +3 more
  • Insulin human
  • +11 more
  • New York, New York
    Columbia University Irving Medical Center
Nov 6, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Prostatic Neoplasms
  • (no location specified)
Nov 21, 2023

Prostate Cancer Metastatic Trial (MK-5684, Abiraterone acetate, Enzalutamide)

Not yet recruiting
  • Prostate Cancer Metastatic
  • (no location specified)
Nov 21, 2023

Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

Active, not recruiting
  • Primary Systemic Amyloidosis
  • Light Chain Deposition Disease
  • Denver, Colorado
  • +6 more
Aug 24, 2022

MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

Recruiting
  • Myelodysplastic Syndromes, de Novo
  • +10 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 23, 2023

Total Knee Replacement, Knee Arthroplasty Trial in New Haven (Bupivacaine-Liposomal Bupivacaine, Bupivacaine -Dexamethasone

Recruiting
  • Total Knee Replacement
  • Knee Arthroplasty
  • Bupivacaine-Liposomal Bupivacaine
  • Bupivacaine -Dexamethasone Sodium Phosphate-Methylprednisolone Acetate
  • New Haven, Connecticut
  • +1 more
Feb 17, 2023

Tinea Trial in Brazil (Candicort®, Nizoral®, Baycuten N®)

Completed
  • Tinea
  • Salvador, Bahia, Brazil
  • +8 more
Sep 16, 2021

Total Knee Replacement, Knee Arthroplasty Trial in New Haven (Bupivacaine-Liposomal Bupivacaine, Bupivacaine -Dexamethasone

Recruiting
  • Total Knee Replacement
  • Knee Arthroplasty
  • Bupivacaine-Liposomal Bupivacaine
  • Bupivacaine -Dexamethasone Sodium Phosphate-Methylprednisolone Acetate
  • New Haven, Connecticut
  • +1 more
Sep 14, 2022

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Oct 23, 2023

Pterygium Trial in New York (Dexamethasone Intracanalicular Insert, 0.4mg, Prednisolone Acetate 1%)

Completed
  • Pterygium
  • Dexamethasone Intracanalicular Insert, 0.4mg
  • Prednisolone Acetate 1%
  • New York, New York
    New York Eye Specialists
Apr 4, 2022

Keratoconus, Unstable, Collagen Crosslinking, Postoperative Pain Trial in Babylon (Dextenza, Prednisolone Acetate)

Active, not recruiting
  • Keratoconus, Unstable
  • +2 more
  • Babylon, New York
    SightMD
Jan 18, 2022

Glaucoma, Cataract Trial in Bronx (Dexamethasone Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp)

Recruiting
  • Glaucoma
  • Cataract
  • Dexamethasone Ophthalmic Insert
  • Prednisolone Acetate 1% Oph Susp
  • Bronx, New York
    The New York Eye Surgery Center
Mar 20, 2022

Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain Trial in Cleveland (Dexamethasone Ophthalmic Insert,

Enrolling by invitation
  • Vitreoretinal Surgery
  • +3 more
  • Dexamethasone Ophthalmic Insert
  • Prednisolone Acetate 1% Oph Susp
  • Cleveland, Ohio
    Cole Eye Institute, Cleveland Clinic
Feb 24, 2022

COVID-19, ARDS Trial in Cairo (Fludrocortisone Acetate 0.1 MG)

Completed
  • COVID-19
  • ARDS
  • Fludrocortisone Acetate 0.1 MG
  • Cairo, Abbasia, Egypt
    Ain Shams University
Jul 9, 2022

Pterygium of Both Eyes Trial in Brandon (Intracanalicular Dexamethasone, (0.4 mg) Insert, Prednisolone Acetate)

Active, not recruiting
  • Pterygium of Both Eyes
  • Intracanalicular Dexamethasone, (0.4 mg) Insert
  • Prednisolone Acetate
  • Brandon, Florida
    Brandon Eye Associates
Jul 19, 2022

Myeloma, Newly Diagnosed, High Risk Trial in GuangZhou (bortezomib, Lenalidomide, Dexamethasone)

Unknown status
  • Myeloma
  • +2 more
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 15, 2020

Congenital Adrenal Hyperplasia Trial in Naples (Conventional Glucocorticoids (immediate release hydrocortisone, cortisone

Recruiting
  • Congenital Adrenal Hyperplasia
  • Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
  • Dual release hydrocortisone (plenadren)
  • Naples, Italy
    Federico II University
Mar 21, 2022

Inflammation Trial (Dexamethasone acetate, Potassium Nitrate)

Completed
  • Inflammation
  • Dexamethasone acetate
  • Potassium Nitrate
  • (no location specified)
Nov 3, 2020

AL Amyloidosis Trial in Boston (Pomalidomide, Dexamethasone)

Completed
  • AL Amyloidosis
  • Boston, Massachusetts
    Boston Medical Center
Sep 3, 2020

Corneal Edema, Corneal Defect, Anterior Chamber Inflammation Trial in Los Angeles (Dextenza 0.4Mg Ophthalmic Insert,

Not yet recruiting
  • Corneal Edema
  • +6 more
  • Dextenza 0.4Mg Ophthalmic Insert
  • +3 more
  • Los Angeles, California
    Advanced Vision Care
Dec 5, 2022

Post Procedural Infection Trial in Brecksville (Dexamethasone ophthalmic insert 0.4 mg)

Completed
  • Post Procedural Infection
  • Dexamethasone ophthalmic insert 0.4 mg
  • Brecksville, Ohio
    Cleveland Eye Clinic
Jul 26, 2021